These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 4049764)
61. Circadian rhythm of growth hormone, free and total insulin during the treatment with artificial B-cell (Biostator GCIIS). Sieradzki J; Szybiński Z; Izworski A; Gołda W Endokrynol Pol; 1983; 34(2):73-80. PubMed ID: 6354700 [No Abstract] [Full Text] [Related]
62. A clinician's perspective on some of the challenges in "closing the loop". Wolpert HA Diabetes Technol Ther; 2003; 5(5):843-6. PubMed ID: 14633349 [No Abstract] [Full Text] [Related]
63. [Comparative pharmacodynamic studies of insulin Maxirapid Polfa and Actrapid MC Novo using Biostator GCIIS]. Sieradzki J Pol Tyg Lek; 1984 Apr; 39(18):615-7. PubMed ID: 6399370 [No Abstract] [Full Text] [Related]
64. Ultrasonic measurement of forearm subcutaneous adipose tissue thickness suitable for monitoring of subcutaneous glucose concentration? Bolinder J; Frid A Diabetes Care; 1989 Apr; 12(4):305-6. PubMed ID: 2707119 [No Abstract] [Full Text] [Related]
66. Exercise: a vital component for patients on the Biostator. Summers S Diabetes Educ; 1984; 10(2):22-4. PubMed ID: 6564950 [No Abstract] [Full Text] [Related]
67. Nursing care of the Biostator patient. Witt L; Fuqua L; Young A; Jones MJ Diabetes Educ; 1984; 10(2):17-21. PubMed ID: 6564949 [No Abstract] [Full Text] [Related]
68. Short-term control of brittle diabetes using a Biostator. Connor H; Atkin G; Attwood E Br Med J (Clin Res Ed); 1982 Nov; 285(6351):1316-7. PubMed ID: 6812693 [No Abstract] [Full Text] [Related]
69. Simple solution to problem of biostator-induced insulin aggregation. Harris MD; Davidson MB; Rosenberg CS Diabetes Care; 1986; 9(4):356-8. PubMed ID: 3527612 [TBL] [Abstract][Full Text] [Related]
70. Maintaining good control in children with diabetes. Faro B Pediatr Nurs; 1983; 9(5):368-73. PubMed ID: 6353343 [No Abstract] [Full Text] [Related]
71. [Unstable type I diabetes mellitus: comparative study between intensive conventional treatment and continuous subcutaneous infusion of insulin]. Levy I; Bergua M; Esmatjes E; Halperin I; Figuerola D Med Clin (Barc); 1984 Oct; 83(13):525-8. PubMed ID: 6392766 [No Abstract] [Full Text] [Related]
72. The glucose sensor. Some results and applications. Christensen SE; Schmitz O; Hansen AP; Orskov H Acta Med Scand Suppl; 1983; 671():121-8. PubMed ID: 6410697 [TBL] [Abstract][Full Text] [Related]
73. Diabetes: controlling the insulin balance. Tight control: what does it mean. Bates S; Ahern JA Am J Nurs; 1986 Nov; 86(11):1256-8. PubMed ID: 3535512 [No Abstract] [Full Text] [Related]
74. [Experience with using automated insulin infusion systems in diabetes mellitus type 1]. Perelygina AA; Antsiferov MV; Starostina EG Sov Med; 1988; (5):72-5. PubMed ID: 3212534 [No Abstract] [Full Text] [Related]
75. [Use of the Biostator in optimizing insulin treatment (preliminary communication)]. Kábrt J; Masek Z; Páv J Vnitr Lek; 1985 Sep; 31(9):870-6. PubMed ID: 4049764 [No Abstract] [Full Text] [Related]